2024 · pending · WO2025240499A1

Treatment of PLOD2 Related Diseases and Disorders

Gregory McInnes

Compositions comprising oligonucleotides (siRNA or ASO) that target PLOD2 for treating conditions associated with PLOD2.

RNA Therapeutics